| __timestamp | Dynavax Technologies Corporation | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84580000 | 581800000 |
| Thursday, January 1, 2015 | 86943000 | 671900000 |
| Friday, January 1, 2016 | 84493000 | 876700000 |
| Sunday, January 1, 2017 | 64988000 | 857900000 |
| Monday, January 1, 2018 | 74951000 | 822200000 |
| Tuesday, January 1, 2019 | 62331000 | 778200000 |
| Wednesday, January 1, 2020 | 28607000 | 512600000 |
| Friday, January 1, 2021 | 32228000 | 681000000 |
| Saturday, January 1, 2022 | 46600000 | 662200000 |
| Sunday, January 1, 2023 | 54886000 | 910700000 |
In pursuit of knowledge
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Viatris Inc. and Dynavax Technologies Corporation have demonstrated contrasting approaches to R&D investment.
Viatris Inc. has consistently increased its R&D spending, peaking in 2023 with a 56% rise from 2014. This commitment underscores their strategy to maintain a competitive edge through innovation.
Conversely, Dynavax Technologies has experienced fluctuations, with a notable dip in 2020, where R&D expenses fell by 66% compared to 2014. However, a recovery is evident by 2023, with a 92% increase from the 2020 low.
These trends highlight the diverse strategies companies employ to navigate the challenges of the pharmaceutical industry, balancing risk and innovation.
R&D Insights: How Novartis AG and Viatris Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Dynavax Technologies Corporation
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Viatris Inc.
R&D Spending Showdown: Viatris Inc. vs Intra-Cellular Therapies, Inc.
Analyzing R&D Budgets: Viatris Inc. vs Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: Viatris Inc. vs Amneal Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Viatris Inc. vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Viatris Inc. and Celldex Therapeutics, Inc.
R&D Insights: How Halozyme Therapeutics, Inc. and Dynavax Technologies Corporation Allocate Funds
Research and Development Investment: Corcept Therapeutics Incorporated vs Dynavax Technologies Corporation
Rhythm Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Invests More in Innovation?
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and Dynavax Technologies Corporation